Subscribe to Newsletter

Peter Seeberger

The Power List 2016

Peter Seeberger

Director at the Max-Planck Institute for Colloids and Interfaces, and Professor, Free University of Berlin

Peter’s research covers a broad range of topics from engineering to immunology, and has been documented in over 420 peer-reviewed journal articles, more than 40 patents, and more than 750 invited lectures. His work on continuous chemistry, which he hopes will make drugs against malaria and HIV more affordable, won him and his collaborator, Andreas Seidel-Morgenstern, the 2015 Humanity in Science Award. “It’s motivating to be able to appear on this list twice!” says Peter. “Since the last list, we’ve had two big breakthroughs: the proof-of-principle for an expanded synthetic vaccine against S. pneumoniae and the development of a continuous process to produce the most important HIV medication. We are also about to submit several manuscripts describing vaccine candidates against dangerous hospital acquired infections.”

Part of the Power List 2016

The Top 100

The nominations are in and after considerable debate and analysis from our judging panel, we present The Power List 2016 – our second foray into the Top 100 most influential people in the world of drug development and manufacture.

Go to The Power List 2016

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine